Abstract

Ovarian cancer is one of the most common gynecological malignancies and has the highest case fatality rate among all gynecological malignancies. Tumor markers are very important for early diagnosis, curative effect monitoring, and prognosis assessment in ovarian cancer. CA125 and HE4 are the most widely used serum tumor markers in ovarian cancer, but they have some flaws. Thus, finding more sensitive and specific tumor markers is of great importance. In recent years, with the rapid development of the second generation sequencing technology, circulating tumor DNA, circulating tumor cells, and miRNA have provided a new train of thought for identifying new tumor markers for ovarian cancer. Key words: Ovarian cancer; Tumor markers; Circulating tumor cells

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.